According to the release, the decision is expected to ease the financial burden on families struggling with life-threatening illnesses such as cancer, chronic kidney disease, and serious infections. “The reduction in GST on critical drugs reflects the Government’s commitment to strengthening public health infrastructure and supporting those battling serious medical conditions,” the association said.
